Ascendis Pharma A/S Announces First Quarter 2019 Financial Results and Business Update Conference Call on May 30

NEXT STORY
BeyondSpring’s Rationale for the Plinabulin-Neulasta Combination for Neutropenia Prevention Accepted as Abstracts at 2019 ASCO Annual Meeting
PREV STORY
Résultats positifs de la plateforme ciblée en oncologie de Theratechnologies présentés en ligne à ASCO
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cytori Reports Fourth Quarter and Full Year 2017 Business and Financial Results

SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ:CYTX) (“Cytori” or the ...

author_avatar
NASDAQ Market News

BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., and BEIJING, China, Nov. 13, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: ...

author_avatar
NASDAQ Market News

VigiLanz Integrates Infectious Disease Content from Sanford Guide

MINNEAPOLIS, MN--(Marketwired - Nov 29, 2017) - VigiLanz, a digital healthcare intelligence firm, announced ...

author_avatar
NASDAQ Market News